LAMP2 regulates autophagy in the thymic epithelium and thymic stroma-dependent CD4 T cell development. 2023

Pedro M Rodrigues, and Laura G Sousa, and Chiara Perrod, and Ana R Maceiras, and Pedro Ferreirinha, and Rita Pombinho, and Gema Romera-Cárdenas, and María Gomez-Lazaro, and Meryem Senkara, and Jelena Pistolic, and Didier Cabanes, and Ludger Klein, and Paul Saftig, and Nuno L Alves
Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.

Within the thymus, thymic epithelial cells (TECs) provide dedicated thymic stroma microenvironments for T cell development. Because TEC functionality is sensitive to aging and cytoablative therapies, unraveling the molecular elements that coordinate their thymopoietic role has fundamental and clinical implications. Particularly, the selection of CD4 T cells depends on interactions between TCRs expressed on T cell precursors and self-peptides:MHC II complexes presented by cortical TECs (cTECs). Although the macroautophagy/autophagy-lysosomal protein degradation pathway is implicated in CD4 T cell selection, the molecular mechanism that controls the generation of selecting MHC II ligands remains elusive. LAMP2 (lysosomal-associated membrane protein 2) is a well-recognized mediator of autolysosome (AL) maturation. We showed that LAMP2 is highly expressed in cTECs. Notably, genetic inactivation of Lamp2 in thymic stromal cells specifically impaired the development of CD4 T cells that completed positive selection, without misdirecting MHC II-restricted cells into the CD8 lineage. Mechanistically, defects in autophagy in lamp2-deficient cTECs were linked to alterations in MHC II processing, which was associated with a marked reduction in CD4 TCR repertoire diversity selected within the lamp2-deficient thymic stroma. Together, our findings suggest that LAMP2 interconnects the autophagy-lysosomal axis and the processing of selecting self-peptides:MHC II complexes in cTECs, underling its implications for the generation of a broad CD4 TCR repertoire.Abbreviations: AIRE: autoimmune regulator (autoimmune polyendocrinopathy candidiasis ectodermal dystrophy); AL: autolysosome; AP: autophagosome; Baf-A1: bafilomycin A1; B2M: beta-2 microglobulin; CTSL: cathepsin L; CD74/Ii: CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated); CFSE: carboxyfluorescein succinimidyl ester; CFU: colony-forming unit; CLIP: class II-associated invariant chain peptides; cTECs: cortical TECs dKO: double knockout; DN: double negative; DP: double positive; ENPEP/LY51: glutamyl aminopeptidase; FOXP3: forkhead box; P3 IFNG/IFNγ: interferon gamma; IKZF2/HELIOS: IKAROS family zinc finger 2; IL2RA/CD25: interleukin 2 receptor, alpha chain; KO: knockout; LAMP2: lysosomal-associated membrane protein 2; LIP: lymphopenia-induced proliferation; Lm: Listeria monocytogenes; MAP1LC3/LC3: microtubule-associated protein 1 light chain 3; MHC: major histocompatibility complex; mTECs: medullary TECs; PRSS16/TSSP: protease, serine 16 (thymus); SELL/CD62L: selectin, lymphocyte; SP: single positive; TCR: T cell receptor; TCRB: T cell receptor beta chain; TECs: thymic epithelial cells; UEA-1: Ulex europaeus agglutinin-1; WT: wild-type.

UI MeSH Term Description Entries
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011948 Receptors, Antigen, T-Cell Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains. Antigen Receptors, T-Cell,T-Cell Receptors,Receptors, T-Cell Antigen,T-Cell Antigen Receptor,T-Cell Receptor,Antigen Receptor, T-Cell,Antigen Receptors, T Cell,Receptor, T-Cell,Receptor, T-Cell Antigen,Receptors, T Cell Antigen,Receptors, T-Cell,T Cell Antigen Receptor,T Cell Receptor,T Cell Receptors,T-Cell Antigen Receptors
D004847 Epithelial Cells Cells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional epithelial cells. Adenomatous Epithelial Cells,Columnar Glandular Epithelial Cells,Cuboidal Glandular Epithelial Cells,Glandular Epithelial Cells,Squamous Cells,Squamous Epithelial Cells,Transitional Epithelial Cells,Adenomatous Epithelial Cell,Cell, Adenomatous Epithelial,Cell, Epithelial,Cell, Glandular Epithelial,Cell, Squamous,Cell, Squamous Epithelial,Cell, Transitional Epithelial,Cells, Adenomatous Epithelial,Cells, Epithelial,Cells, Glandular Epithelial,Cells, Squamous,Cells, Squamous Epithelial,Cells, Transitional Epithelial,Epithelial Cell,Epithelial Cell, Adenomatous,Epithelial Cell, Glandular,Epithelial Cell, Squamous,Epithelial Cell, Transitional,Epithelial Cells, Adenomatous,Epithelial Cells, Glandular,Epithelial Cells, Squamous,Epithelial Cells, Transitional,Glandular Epithelial Cell,Squamous Cell,Squamous Epithelial Cell,Transitional Epithelial Cell
D004848 Epithelium The layers of EPITHELIAL CELLS which cover the inner and outer surfaces of the cutaneous, mucus, and serous tissues and glands of the body. Mesothelium,Epithelial Tissue,Mesothelial Tissue,Epithelial Tissues,Mesothelial Tissues,Tissue, Epithelial,Tissue, Mesothelial,Tissues, Epithelial,Tissues, Mesothelial
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000949 Histocompatibility Antigens Class II Large, transmembrane, non-covalently linked glycoproteins (alpha and beta). Both chains can be polymorphic although there is more structural variation in the beta chains. The class II antigens in humans are called HLA-D ANTIGENS and are coded by a gene on chromosome 6. In mice, two genes named IA and IE on chromosome 17 code for the H-2 antigens. The antigens are found on B-lymphocytes, macrophages, epidermal cells, and sperm and are thought to mediate the competence of and cellular cooperation in the immune response. The term IA antigens used to refer only to the proteins encoded by the IA genes in the mouse, but is now used as a generic term for any class II histocompatibility antigen. Antigens, Immune Response,Class II Antigens,Class II Histocompatibility Antigen,Class II Major Histocompatibility Antigen,Ia Antigens,Ia-Like Antigen,Ia-Like Antigens,Immune Response Antigens,Immune-Associated Antigens,Immune-Response-Associated Antigens,MHC Class II Molecule,MHC II Peptide,Class II Antigen,Class II Histocompatibility Antigens,Class II MHC Proteins,Class II Major Histocompatibility Antigens,Class II Major Histocompatibility Molecules,I-A Antigen,I-A-Antigen,IA Antigen,MHC Class II Molecules,MHC II Peptides,MHC-II Molecules,Antigen, Class II,Antigen, I-A,Antigen, IA,Antigen, Ia-Like,Antigens, Class II,Antigens, Ia,Antigens, Ia-Like,Antigens, Immune-Associated,Antigens, Immune-Response-Associated,I A Antigen,II Peptide, MHC,Ia Like Antigen,Ia Like Antigens,Immune Associated Antigens,Immune Response Associated Antigens,MHC II Molecules,Molecules, MHC-II,Peptide, MHC II,Peptides, MHC II
D001343 Autophagy The segregation and degradation of various cytoplasmic constituents via engulfment by MULTIVESICULAR BODIES; VACUOLES; or AUTOPHAGOSOMES and their digestion by LYSOSOMES. It plays an important role in BIOLOGICAL METAMORPHOSIS and in the removal of bone by OSTEOCLASTS. Defective autophagy is associated with various diseases, including NEURODEGENERATIVE DISEASES and cancer. Autophagocytosis,ER-Phagy,Lipophagy,Nucleophagy,Reticulophagy,Ribophagy,Autophagy, Cellular,Cellular Autophagy,ER Phagy
D013950 Thymus Gland A single, unpaired primary lymphoid organ situated in the MEDIASTINUM, extending superiorly into the neck to the lower edge of the THYROID GLAND and inferiorly to the fourth costal cartilage. It is necessary for normal development of immunologic function early in life. By puberty, it begins to involute and much of the tissue is replaced by fat. Thymus,Gland, Thymus,Glands, Thymus,Thymus Glands
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte

Related Publications

Pedro M Rodrigues, and Laura G Sousa, and Chiara Perrod, and Ana R Maceiras, and Pedro Ferreirinha, and Rita Pombinho, and Gema Romera-Cárdenas, and María Gomez-Lazaro, and Meryem Senkara, and Jelena Pistolic, and Didier Cabanes, and Ludger Klein, and Paul Saftig, and Nuno L Alves
September 2008, Nature,
Pedro M Rodrigues, and Laura G Sousa, and Chiara Perrod, and Ana R Maceiras, and Pedro Ferreirinha, and Rita Pombinho, and Gema Romera-Cárdenas, and María Gomez-Lazaro, and Meryem Senkara, and Jelena Pistolic, and Didier Cabanes, and Ludger Klein, and Paul Saftig, and Nuno L Alves
June 1996, Immunity,
Pedro M Rodrigues, and Laura G Sousa, and Chiara Perrod, and Ana R Maceiras, and Pedro Ferreirinha, and Rita Pombinho, and Gema Romera-Cárdenas, and María Gomez-Lazaro, and Meryem Senkara, and Jelena Pistolic, and Didier Cabanes, and Ludger Klein, and Paul Saftig, and Nuno L Alves
October 2022, Proceedings of the National Academy of Sciences of the United States of America,
Pedro M Rodrigues, and Laura G Sousa, and Chiara Perrod, and Ana R Maceiras, and Pedro Ferreirinha, and Rita Pombinho, and Gema Romera-Cárdenas, and María Gomez-Lazaro, and Meryem Senkara, and Jelena Pistolic, and Didier Cabanes, and Ludger Klein, and Paul Saftig, and Nuno L Alves
July 2004, The Journal of experimental medicine,
Pedro M Rodrigues, and Laura G Sousa, and Chiara Perrod, and Ana R Maceiras, and Pedro Ferreirinha, and Rita Pombinho, and Gema Romera-Cárdenas, and María Gomez-Lazaro, and Meryem Senkara, and Jelena Pistolic, and Didier Cabanes, and Ludger Klein, and Paul Saftig, and Nuno L Alves
January 1989, International immunology,
Pedro M Rodrigues, and Laura G Sousa, and Chiara Perrod, and Ana R Maceiras, and Pedro Ferreirinha, and Rita Pombinho, and Gema Romera-Cárdenas, and María Gomez-Lazaro, and Meryem Senkara, and Jelena Pistolic, and Didier Cabanes, and Ludger Klein, and Paul Saftig, and Nuno L Alves
January 1990, Thymus,
Pedro M Rodrigues, and Laura G Sousa, and Chiara Perrod, and Ana R Maceiras, and Pedro Ferreirinha, and Rita Pombinho, and Gema Romera-Cárdenas, and María Gomez-Lazaro, and Meryem Senkara, and Jelena Pistolic, and Didier Cabanes, and Ludger Klein, and Paul Saftig, and Nuno L Alves
May 2012, Proceedings of the National Academy of Sciences of the United States of America,
Pedro M Rodrigues, and Laura G Sousa, and Chiara Perrod, and Ana R Maceiras, and Pedro Ferreirinha, and Rita Pombinho, and Gema Romera-Cárdenas, and María Gomez-Lazaro, and Meryem Senkara, and Jelena Pistolic, and Didier Cabanes, and Ludger Klein, and Paul Saftig, and Nuno L Alves
November 2023, Science immunology,
Pedro M Rodrigues, and Laura G Sousa, and Chiara Perrod, and Ana R Maceiras, and Pedro Ferreirinha, and Rita Pombinho, and Gema Romera-Cárdenas, and María Gomez-Lazaro, and Meryem Senkara, and Jelena Pistolic, and Didier Cabanes, and Ludger Klein, and Paul Saftig, and Nuno L Alves
March 2013, Journal of leukocyte biology,
Pedro M Rodrigues, and Laura G Sousa, and Chiara Perrod, and Ana R Maceiras, and Pedro Ferreirinha, and Rita Pombinho, and Gema Romera-Cárdenas, and María Gomez-Lazaro, and Meryem Senkara, and Jelena Pistolic, and Didier Cabanes, and Ludger Klein, and Paul Saftig, and Nuno L Alves
September 2007, The Journal of experimental medicine,
Copied contents to your clipboard!